Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 169 到 179 筆資料,總共 179 筆
< 上一頁
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2011
WJ9708012 exerts anticancer activity through PKC-α related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells
Kuo T.-C.; Huang W.-J.; JIH-HWA GUH
Acta Pharmacologica Sinica
8
7
2008
WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: Identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers
Hsiao C.-J.; TSAI-KUN LI
; Chan Y.-L.; LING-WEI HSIN
; Liao C.-H.; Lee C.-H.; Lyu P.-C.; JIH-HWA GUH
Biochemical Pharmacology
35
32
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G 0-G1 in human hepatocellular carcinoma cells
Wang S.-W.; Pan S.-L.; JIH-HWA GUH
; Chen H.-L.; Huang D.-M.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
47
47
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
Pan S.-L.; JIH-HWA GUH
; Peng C.-Y.; Wang S.-W.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
55
53
2006
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH
; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
39
33
2008
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway
Wu S.Y.; Pan S.L.; Chen T.H.; Liao C.H.; Huang D.Y.; JIH-HWA GUH
; Chang Y.L.; Kuo S.C.; Lee F.Y.; Teng C.M.
British Journal of Pharmacology
25
25
2008
YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH
; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Shock
12
10
2007
YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia
Sun H.-L.; Liu Y.-N.; Huang Y.-T.; Pan S.-L.; Huang D.-Y.; JIH-HWA GUH
; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
Oncogene
163
158
2004
YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells
Pan S.L.; JIH-HWA GUH
; Chang Y.L.; Kuo S.C.; Lee F.Y.; Teng C.M.
Cardiovascular Research
36
32
2005
YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells
Huang Y.-T.; Pan S.-L.; JIH-HWA GUH
; Chang Y.-L.; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
Molecular Cancer Therapeutics
45
43
2015
Zerumbone, a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult
Chan M.-L.; Liang J.-W.; LIH-CHING HSU
; Chang W.-L.; SHOEI-SHENG LEE
; JIH-HWA GUH
Naunyn-Schmiedeberg's Archives of Pharmacology
39
33